(RTTNews) - At the Annual General Meeting, Paul McKenzie, Chief Executive Officer of CSL Ltd. (CSL.AX), reaffirmed the company's financial guidance for fiscal year 2025. The company still expects ...

Shares of building envelope solutions provider Carlisle Companies (NYSE:CSL) fell 8.4% in the morning session after the company reported disappointing third-quarter earnings results. Its revenue ...

Carlisle Companies Inc (NYSE:CSL) achieved record third-quarter results in both EBITDA margin and earnings per share, despite challenges in the residential market and weather-related disruptions.

The $1.25 million CSL Centenary Fellowship has enabled Dr Weeden to return from the Crick Institute in London to establish her own research laboratory at WEHI in Melbourne. She plans to identify how ...

I suddenly changed my mind when I started working with a renowned Italian driver who had brought in a BMW M3 E92 GT4 ... Some might say it's the 3.0-CSL, but is that attainable or worth it ...

CSL has pulled studies or trials on three therapies and says US regulators have raised manufacturing concerns about a key new treatment in rare late-stage setbacks for the biotechnology giant’s ...

CSL (AU:CSL) has released an update. CSL Limited is hosting its 2024 Research & Development Investor Briefing, offering investors insights into the company’s latest innovations and strategic ...

Bell Potter highlights that there is a lot to like about CSL. It notes that the company holds the number one and number two positions in its three key markets. These are plasma-derived therapies ...

CSL Ltd (ASX: CSL) shares could be one of the best options out there for investors right now. That's the view of analysts at Bell Potter, which have named the biotechnology company on their ...

ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic has granted temporary marketing ...